Seely Lynn

CIK 00013271114 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001327111

Recent Transactions

50 trades

Sale
Lyell Immunopharma, Inc.$LYEL
Common Stock
2026-02-11$23.39/sh−7,455→ 74,266 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2026-02-10+155,000→ 155,000 total
Sale
Lyell Immunopharma, Inc.$LYEL
Common Stock
2026-02-10$23.12/sh−438→ 81,721 total
Award
Lyell Immunopharma, Inc.$LYEL
Common Stock
2026-02-09+20,000→ 82,159 total
Sale
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-11-10$16.11/sh−412→ 67,159 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2025-10-27+175,000→ 175,000 total
Sale
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-08-21$10.54/sh−7,257→ 67,571 total
Award
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-08-20+40,000→ 74,828 total
Sale
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-08-12$10.34/sh−406→ 34,828 total
Sale
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-08-11$10.53/sh−391→ 35,234 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,570→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−7,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−10,909→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,875→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−3,902→ 13,254 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−10,909→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−21,818→ 0 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−13,254→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,500→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-06-18$128.12/sh+3,902→ 17,156 total
Purchase
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-03-14$0.61/sh+175,000→ 712,500 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2025-02-10+168,750→ 168,750 total
Award
Lyell Immunopharma, Inc.$LYEL
Common Stock
2025-02-10+337,500→ 537,500 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2025-02-10+1,350,000→ 1,350,000 total
Award
Blueprint Medicines Corp
Common Stock
2024-06-12+2,242→ 13,254 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-06-12+4,570→ 4,570 total
Award
Lyell Immunopharma, Inc.$LYEL
Common Stock
2024-02-09+200,000→ 200,000 total
Disposition to Issuer
Lyell Immunopharma, Inc.$LYEL
Stock Option (right to buy)
2023-11-16−7,500,000→ 0 total
Award
Lyell Immunopharma, Inc.$LYEL
Stock Option (right to buy)
2023-11-16+7,500,000→ 7,500,000 total
Award
Blueprint Medicines Corp
Common Stock
2023-06-21+2,600→ 11,012 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-06-21+5,300→ 5,300 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2022-12-15+7,500,000→ 7,500,000 total
Award
Blueprint Medicines Corp
Common Stock
2022-06-21+2,600→ 8,412 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-06-21+5,300→ 5,300 total
Award
Lyell Immunopharma, Inc.$LYEL
Option (right to buy)
2022-06-08+65,000→ 65,000 total
Award
Blueprint Medicines Corp
Common Stock
2021-06-02+2,250→ 5,812 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-06-02+4,500→ 4,500 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2020-06-24+4,500→ 4,500 total
Award
Blueprint Medicines Corp
Common Stock
2020-06-24+2,250→ 3,562 total
Exercise/Conversion
Blueprint Medicines Corp
Restricted Stock Units
2020-06-19−1,312→ 0 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2020-06-19+1,312→ 1,312 total
Award
Myovant Sciences Ltd.
Employee Stock Option (Right to Buy)
2020-04-03+302,693→ 302,693 total
Award
Myovant Sciences Ltd.
Common Shares
2020-04-03+197,659→ 1,043,824 total
Award
Blueprint Medicines Corp
Restricted Stock Units
2019-06-19+1,312→ 1,312 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2019-06-19+4,875→ 4,875 total
Award
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2019-04-05+330,660→ 330,660 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2018-06-21+7,500→ 51,136 total

Companies

Recent Filings

Address

C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov